How has been the historical performance of SMS Lifesciences?

Nov 15 2025 12:19 AM IST
share
Share Via
SMS Lifesciences showed improved financial performance in Mar'25, with net sales rising to 344.72 Cr and profit before tax increasing to 26.19 Cr, despite a decline from Mar'22 levels. The company also reported a significant rise in operating profit margin and earnings per share, indicating a recovery in profitability and operational efficiency.
Answer:
The historical performance of SMS Lifesciences shows a fluctuating trend in key financial metrics over the years.

Breakdown:
SMS Lifesciences reported net sales of 344.72 Cr in Mar'25, an increase from 305.96 Cr in Mar'24, but a decline from 349.74 Cr in Mar'22. The total operating income mirrored this trend, reaching 344.72 Cr in Mar'25. The company’s total expenditure, excluding depreciation, was 299.68 Cr in Mar'25, up from 274.84 Cr in Mar'24. Operating profit, excluding other income, improved to 45.04 Cr in Mar'25 from 31.12 Cr in the previous year, resulting in an operating profit margin of 13.07%. Profit before tax surged to 26.19 Cr in Mar'25, significantly higher than 9.85 Cr in Mar'24, while profit after tax also rose to 18.73 Cr from 6.33 Cr. The consolidated net profit for Mar'25 was 20.11 Cr, compared to 9.09 Cr in Mar'24. The earnings per share (EPS) increased to 66.59 in Mar'25 from 30.1 in Mar'24. On the balance sheet, total liabilities slightly decreased to 389.99 Cr in Mar'25 from 391.33 Cr in Mar'24, with total assets also declining to 389.99 Cr. Cash flow from operating activities improved to 34.00 Cr in Mar'25 from 24.00 Cr in Mar'24, while cash flow from investing activities remained negative at -15.00 Cr. Overall, SMS Lifesciences demonstrated a recovery in profitability and operational efficiency in Mar'25 compared to the previous year.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News